Ketorolac tromethamine 0.5 % ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial

被引:0
|
作者
Akpek, EK
Karadayi, K
机构
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:662 / 663
页数:2
相关论文
共 50 条
  • [21] Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery - Prospective randomized double-masked clinical trial
    Duong, Hon-Vu Q.
    Westfield, Kenneth C.
    Chalkley, Thomas H. F.
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2007, 33 (11): : 1925 - 1929
  • [22] Efficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgery
    Weber, Michel
    Kodjikian, Laurent
    Kruse, Friedrich E.
    Zagorski, Zbigniew
    Allaire, Catherine M.
    ACTA OPHTHALMOLOGICA, 2013, 91 (01) : e15 - e21
  • [23] Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2)
    Gaddie, Ian Benjamin
    Donnenfeld, Eric D.
    Karpecki, Paul
    Vollmer, Patrick
    Berdy, Gregg J.
    Peterson, Jared D.
    Edell, Aimee R. P.
    Simmons, Blake
    Whitson, William E.
    Ciolino, Joseph B.
    Baba, Stephanie N.
    Holdbrook, Mark
    Trevejo, Jose
    Meyer, John
    Yeu, Elizabeth
    OPHTHALMOLOGY, 2023, 130 (10) : 1015 - 1023
  • [24] Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea
    Brenenman, D
    Savin, R
    VandePol, C
    Vamvakias, G
    Levy, S
    Leyden, J
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2004, 43 (05) : 381 - 387
  • [25] Efficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgery
    Rajpal, Rajesh K.
    Roel, Lawrence
    Siou-Mermet, Raphaele
    Erb, Tara
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2013, 39 (02): : 158 - 167
  • [26] Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis
    Warshaw, Erin M.
    Wohlhuter, Ross Jon
    Liu, An
    Zeller, Sarah A.
    Wenner, Rachel A.
    Bowers, Sacharitha
    Schultz, Julie C.
    Katz, H. Irving
    McCormick, Calogera L.
    Parneix-Spake, Anne
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (02) : 257 - 264
  • [27] RESULTS OF A PROSPECTIVE, MULTI-CENTERED, RANDOMIZED VEHICLE-CONTROLLED AND PLACEBO-CONTROLLED CLINICAL-TRIAL OF FIBRONECTIN OPHTHALMIC SOLUTION IN PATIENTS WITH KERATOCONJUNCTIVITIS SICCA (KCS)
    NELSON, JD
    GORDON, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 726 - 726
  • [28] Treatment of Demodex Blepharitis with Lotilaner Ophthalmic Solution, 0.25%: Combined Analysis of Two Pivotal Randomized, Vehicle-Controlled, Multicenter Trials
    Yeu, Elizabeth
    Mun, James J.
    Vollmer, Patrick
    Ciolino, Joseph B.
    Holdbrook, Mark
    Baba, Stephanie
    Whitson, William
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [29] Topical isoniazid as a novel treatment for melasma: A randomized, double-blind, vehicle-controlled clinical trial
    Ahramiyanpour, Najmeh
    Mahmoudi, Zahra
    Nezhad, Nazanin Zeinali
    Khazaeli, Payam
    Amiri, Rezvan
    Kasraee, Behrooz
    JOURNAL OF COSMETIC DERMATOLOGY, 2024, 23 (08) : 2636 - 2643
  • [30] Phase I/II, Double-Masked, Randomized, Vehicle-Controlled Study of H-1337 Ophthalmic Solution for Glaucoma and Ocular Hypertension
    Hartman, Paul J.
    Cooke, David L.
    Hsu, Henry H.
    Stewart, Jeanette
    Sumi, Kengo
    Yoshida, Yoko
    Hidaka, Hiroyoshi
    Novack, Gary D.
    OPHTHALMOLOGY GLAUCOMA, 2023, 6 (02): : 198 - 205